CILcare, a CRO entirely dedicated to ear disorders, announces the opening of a new subsidiary in Copenhagen, Denmark. Already established in the US, the French company is joining the Medicon Valley Alliance, an international life-sciences cluster in Northern Europe.
This second subsidiary is another step in CILcare’s “continuing global expansion and will reinforce its presence in the Nordic and Northern European markets,” according to the company. Operating worldwide, CILcare supports the development of potential drugs, gene therapies, implantable devices, and drug delivery technologies that can address the prevention, treatment, or restoration of the hearing function.
“Denmark is the #1 ‘Hearing Country,’“ said CEO Celia Belline. “Almost 50% of the world’s hearing aids are being manufactured in Denmark and people care about hearing. We already have clients, prospects, and potential partners, to whom we want to get closer. We like the mindset, the dynamism, and the beauty of the country and we feel home in Copenhagen.”
CILcare’s new subsidiary is part of the strategy of service offering expansion.
“In addition to preclinical development, we need to develop tools and protocols that will help to better diagnose patients with hearing disorders and better monitor the effect of new therapeutics, so that they have a chance to demonstrate their efficacy and reach the market,” said Dr Wahid Awad, CILcare’s Chief Business Officer. “Our hypothesis, based on our own expertise and supported by emerging literature, is that human hearing profiles might help predict the evolution of several diseases, including neurodegenerative, psychiatric, and inflammatory diseases. In Denmark, we think we can find the right partners, medtechs, pharmas, biotechs, academics, physicians, patient associations, and institutions to help CILcare with its mission: MAKING HEARING A PRIORITY.
“The healthcare and life sciences ecosystem in Copenhagen and Denmark is extremely dynamic, and business is based on trust and building strong and long-term relationships, which are values we admire at CILcare,” he said.
Source: CILcare
